Skip to main content
James Hart, MD, Thoracic Surgery, Fairfax, VA

JamesClarkHartMDFACS FACC

Thoracic Surgery Fairfax, VA

Chief Medical Officer, Global Surgery Group, Johnson & Johnson- retired

Dr. Hart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hart's full profile

Already have an account?

  • Office

    3979 Ballynahown Circle
    Fairfax, VA 22030
    Phone+1 862-229-3396

Education & Training

  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Thoracic Surgery, 1982 - 1983
  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Surgery, 1981 - 1982
  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Surgery, 1977 - 1978
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 1977
  • Carnegie Mellon University
    Carnegie Mellon UniversityBA, Chemistry, 1969 - 1973

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1978 - 2014

Awards, Honors, & Recognition

  • Johnson Medal recipient for Research and Development Johnson & Johnson, 2012
  • Affiliate Award for Student Research American Heart Association Pennsylvania
  • Tau Beta Pi National Engineering Honorary Society
  • Join now to see all

Publications & Presentations

Journal Articles

  • A prospective, randomized, controlled trial of the efficacy and safety of fibrin pad as an adjunct to control soft tissue bleeding during abdominal, retroperitoneal, p...  
    Fischer CO, Bochicchio G, Shen J, et. Al, J Am Col Surg, 1/1/2013
  • A phase III, randomized, controlled, superiority trial evaluating the fibrin pad versus standard of care in controlling parenchymal bleeding during elective hepatic su...  
    Koea JB, Batiller J, Patel B, et. Al, HBP, 1/1/2013
  • Safety and hemostatic efficacy of fibrin pad in partial nephrectomy; Results of an open-label Phase I and randomized, standard-of-care-controlled Phase I/II study  
    Nativ O, Patel B, Shen J, et. Al, BMC Nephrology, 1/1/2012
  • Join now to see all

Abstracts/Posters

  • Fibrin Pad: A Novel Hemostatic Products
    Hart, J, American Heart Association Annual Scientific Sessions, Resuscitation Science Symposium 2008, Horizons in Resuscitation Devices and Diagnostics, 11/8/2009
  • Innovations in CV Surgery
    Hart, J, Asian Society for Cardiovascular Surgery, Singapore, 3/1/2008
  • Plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing cardiovascular, neurologic, and general surgery
    Doria C, Fischer CP, Wood CG, Li PM, Marra S, Hart J, Society for the Advancement of Blood Management, Hollywood, CA, 9/8/2007
  • Join now to see all

Professional Memberships